Alnylam Pharmaceuticals
ALNY
#510
Rank
โ‚น4.317 T
Marketcap
โ‚น32,677
Share price
-0.17%
Change (1 day)
42.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company